Advertisement

Epilepsy and Immune System: A Tour Around the Current Literature

  • Laura Mumoli
  • Angelo Labate
  • Antonietta Coppola
  • Giovambattista De Sarro
  • Emilio RussoEmail author
  • Antonio Gambardella
Chapter
Part of the Contemporary Clinical Neuroscience book series (CCNE)

Abstract

It is widely acknowledged that immune system influences several aspects of the central nervous system. Literature data have shown that immune system and autoimmune response play an important role in the pathogenesis of several neurodegenerative/neurological diseases (i.e Parkinson’s and Alzheimer’s Diseases, Multiple Sclerosis). However, very recent evidences of specific antibodies found in epileptic encephalitis, the good response to immune therapy in refractory epileptic syndromes and the strong relationship between systemic autoimmune disease and epilepsy suggest a plausible role for the immune system also in paroxysmal neurological disorders. In fact, an immune hypothesis represents a new way to approach epilepsy and could contribute to clarify several unanswered questions in the next future. In this review, we analysed these points mimicking a tour around current evidences from experimental animal models to clinical suggestions.

Keywords

Immune system Epilepsy Autoimmune Animal models 

References

  1. Aarli JA (2000) Epilepsy and the immune system. Arch Neurol 57:1689–1692PubMedGoogle Scholar
  2. Afshari M, Afshari ZS, Schuele SU (2012) Pearls & oy-sters: hashimoto encephalopathy. Neurology 78:e134–137PubMedGoogle Scholar
  3. Ahmadi A, Sayyah M, Khoshkholgh-Sima B, Choopani S, Kazemi J, Sadegh M, Moradpour F, Nahrevanian H (2013) Intra-hippocampal injection of lipopolysaccharide inhibits kindled seizures and retards kindling rate in adult rats. Exp Brain Res 226:107–120PubMedGoogle Scholar
  4. Arican N, Kaya M, Kalayci R, Uzun H, Ahishali B, Bilgic B, Elmas I, Kucuk M, Gurses C, Uzun M (2006) Effects of lipopolysaccharide on blood-brain barrier permeability during pentylenetetrazole-induced epileptic seizures in rats. Life Sci 79:1–7PubMedGoogle Scholar
  5. Asztely F, Kumlien E (2012) The diagnosis and treatment of limbic encephalitis. Acta Neurol Scand 126:365–375PubMedGoogle Scholar
  6. Auvin S, Shin D, Mazarati A, Nakagawa J, Miyamoto J, Sankar R (2007) Inflammation exacerbates seizure-induced injury in the immature brain. Epilepsia 48(Suppl 5):27–34PubMedGoogle Scholar
  7. Auvin S, Porta N, Nehlig A, Lecointe C, Vallee L, Bordet R (2009) Inflammation in rat pups subjected to short hyperthermic seizures enhances brain long-term excitability. Epilepsy Res 86:124–130PubMedGoogle Scholar
  8. Auvin S, Mazarati A, Shin D, Sankar R (2010a) Inflammation enhances epileptogenesis in the developing rat brain. Neurobiol Dis 40:303–310PubMedCentralPubMedGoogle Scholar
  9. Auvin S, Shin D, Mazarati A, Sankar R (2010b) Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA. Epilepsia 51(Suppl 3):34–38PubMedCentralPubMedGoogle Scholar
  10. Auvin S, Bellavoine V, Merdariu D, Delanoe C, Elmaleh-Berges M, Gressens P, Boespflug-Tanguy O (2012) Hemiconvulsion-hemiplegia-epilepsy syndrome: current understandings. Eur J Paediatr Neurol 16:413–421PubMedGoogle Scholar
  11. Balosso S, Maroso M, Sanchez-Alavez M, Ravizza T, Frasca A, Bartfai T, Vezzani A (2008) A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain 131:3256–3265PubMedCentralPubMedGoogle Scholar
  12. Balosso S, Ravizza T, Pierucci M, Calcagno E, Invernizzi R, Di Giovanni G, Esposito E, Vezzani A (2009) Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility. Neuroscience 161:293–300.PubMedGoogle Scholar
  13. Baram TZ, Schultz L (1991) Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Dev Brain Res 61:97–101PubMedCentralPubMedGoogle Scholar
  14. Baram TZ, Mitchell WG, Snead OC 3rd, Horton EJ, Saito M (1992) Brain-adrenal axis hormones are altered in the CSF of infants with massive infantile spasms. Neurology 42:1171–1175PubMedCentralPubMedGoogle Scholar
  15. Bauer J, Elger CE, Hans VH, Schramm J, Urbach H, Lassmann H, Bien CG (2007) Astrocytes are a specific immunological target in Rasmussen’s encephalitis. Ann Neurol 62:67–80PubMedGoogle Scholar
  16. Beghi E, Shorvon S (2011) Antiepileptic drugs and the immune system. Epilepsia 52(Suppl 3):40–44PubMedGoogle Scholar
  17. Berger I, Castiel Y, Dor T (2010) Paediatric Hashimoto encephalopathy, refractory epilepsy and immunoglobulin treatment—unusual case report and review of the literature. Acta Paediatr 99:1903–1905PubMedGoogle Scholar
  18. Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, Wiestler OD, Schramm J, Elger CE, Lassmann H (2002) Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen’s encephalitis. Ann Neurol 51:311–318PubMedGoogle Scholar
  19. Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, Lassmann H, Mantegazza R, Villemure JG, Spreafico R, Elger CE (2005) Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 128:454–471PubMedGoogle Scholar
  20. Billiau AD, Wouters CH, Lagae LG (2005) Epilepsy and the immune system: is there a link? Eur J Paediatr Neurol 9:29–42PubMedGoogle Scholar
  21. Chi H (2012) Regulation and function of mTOR signalling in T cell fate decisions. Nat Rev Immunol 12:325–338PubMedCentralPubMedGoogle Scholar
  22. Chinchilla D, Dulac O, Robain O, Plouin P, Ponsot G, Pinel JF, Graber D (1994) Reappraisal of Rasmussen’s syndrome with special emphasis on treatment with high doses of steroids. J Neurol Neurosurg Psychiatry 57:1325–1333PubMedCentralPubMedGoogle Scholar
  23. Chong JY, Rowland LP, Utiger RD (2003) Hashimoto encephalopathy: syndrome or myth? Arch Neurol 60:164–171PubMedGoogle Scholar
  24. Connolly AM, Chez MG, Pestronk A, Arnold ST, Mehta S, Deuel RK (1999) Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J Pediatr 134:607–613PubMedGoogle Scholar
  25. Connolly AM, Chez M, Streif EM, Keeling RM, Golumbek PT, Kwon JM, Riviello JJ, Robinson RG, Neuman RJ, Deuel RM (2006) Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry 59:354–363PubMedGoogle Scholar
  26. Corsellis JA, Goldberg GJ, Norton AR (1968) “Limbic encephalitis” and its association with carcinoma. Brain 91:481–496PubMedGoogle Scholar
  27. Cronin CC, Jackson LM, Feighery C, Shanahan F, Abuzakouk M, Ryder DQ, Whelton M, Callaghan N (1998) Coeliac disease and epilepsy. QJM 91:303–308PubMedGoogle Scholar
  28. Curatolo P, Moavero R (2013) mTOR inhibitors as a new therapeutic option for epilepsy. Expert Rev Neurother 13:627–638PubMedGoogle Scholar
  29. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63–74PubMedCentralPubMedGoogle Scholar
  30. Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA (2013) Glia and epilepsy: excitability and inflammation. Trends Neurosci 36:174–184PubMedGoogle Scholar
  31. Dhote F, Peinnequin A, Carpentier P, Baille V, Delacour C, Foquin A, Lallement G, Dorandeu F (2007) Prolonged inflammatory gene response following soman-induced seizures in mice. Toxicology 238:166–176PubMedGoogle Scholar
  32. Dmowska M, Cybulska R, Schoenborn R, Piersiak T, Jaworska-Adamu J, Gawron A (2010) Behavioural and histological effects of preconditioning with lipopolysaccharide in epileptic rats. Neurochem Res 35:262–272PubMedGoogle Scholar
  33. Drake WE Jr, Macrae D (1961) Epilepsy in multiple sclerosis. Neurology 11:810–816PubMedGoogle Scholar
  34. Duffey P, Yee S, Reid IN, Bridges LR (2003) Hashimoto’s encephalopathy: postmortem findings after fatal status epilepticus. Neurology 61:1124–1126PubMedGoogle Scholar
  35. Emami MH, Taheri H, Kohestani S, Chitsaz A, Etemadifar M, Karimi S, Eshagi MA, Hashemi M (2008) How frequent is celiac disease among epileptic patients? J Gastrointestin Liver Dis 17:379–382PubMedGoogle Scholar
  36. Eriksson K, Peltola J, Keranen T, Haapala AM, Koivikko M (2001) High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases. Epilepsy Res 46:129–137PubMedGoogle Scholar
  37. Fayad MN, Choueiri R, Mikati M (1997) Landau-Kleffner syndrome: consistent response to repeated intravenous gamma-globulin doses: a case report. Epilepsia 38:489–494PubMedGoogle Scholar
  38. Ferlazzo E, Raffaele M, Mazzu I, Pisani F (2006) Recurrent status epilepticus as the main feature of Hashimoto's encephalopathy. Epilepsy Behav 8:328–330PubMedGoogle Scholar
  39. Firlik KS, Adelson PD, Hamilton RL (1999) Coexistence of a ganglioglioma and Rasmussen's encephalitis. Pediatr Neurosurg 30:278–282PubMedGoogle Scholar
  40. Foresti ML, Arisi GM, Shapiro LA (2011) Role of glia in epilepsy-associated neuropathology, neuroinflammation and neurogenesis. Brain Res Rev 66:115–122PubMedGoogle Scholar
  41. Friedman A, Dingledine R (2011) Molecular cascades that mediate the influence of inflammation on epilepsy. Epilepsia 52(Suppl 3):33–39PubMedCentralPubMedGoogle Scholar
  42. Galic MA, Riazi K, Henderson AK, Tsutsui S, Pittman QJ (2009) Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol Dis 36:343–351PubMedCentralPubMedGoogle Scholar
  43. Galic MA, Riazi K, Pittman QJ (2012) Cytokines and brain excitability. Front Neuroendocrinol 33:116–125PubMedCentralPubMedGoogle Scholar
  44. Gambardella A, Valentino P, Labate A, Sibilia G, Ruscica F, Colosimo E, Nistico R, Messina D, Zappia M, Quattrone A (2003) Temporal lobe epilepsy as a unique manifestation of multiple sclerosis. Can J Neurol Sci 30:228–232PubMedGoogle Scholar
  45. Gambardella A, Andermann F, Shorvon S, Le Piane E, Aguglia U (2008) Limited chronic focal encephalitis: another variant of Rasmussen syndrome? Neurology 70:374–377PubMedGoogle Scholar
  46. Geschwind MD, Tan KM, Lennon VA, Barajas RF Jr, Haman A, Klein CJ, Josephson SA, Pittock SJ (2008) Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol 65:1341–1346PubMedCentralPubMedGoogle Scholar
  47. Ghezzi A, Montanini R, Basso PF, Zaffaroni M, Massimo E, Cazzullo CL (1990) Epilepsy in multiple sclerosis. Eur Neurol 30:218–223PubMedGoogle Scholar
  48. Goldberg EM, Coulter DA (2013) Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nat Rev Neurosci 14:337–349PubMedCentralPubMedGoogle Scholar
  49. Granata T, Fusco L, Gobbi G, Freri E, Ragona F, Broggi G, Mantegazza R, Giordano L, Villani F, Capovilla G, Vigevano F, Bernardina BD, Spreafico R, Antozzi C (2003a) Experience with immunomodulatory treatments in Rasmussen’s encephalitis. Neurology 61:1807–1810PubMedGoogle Scholar
  50. Granata T, Gobbi G, Spreafico R, Vigevano F, Capovilla G, Ragona F, Freri E, Chiapparini L, Bernasconi P, Giordano L, Bertani G, Casazza M, Dalla Bernardina B, Fusco L (2003b) Rasmussen’s encephalitis: early characteristics allow diagnosis. Neurology 60:422–425PubMedGoogle Scholar
  51. Granata T, Cross H, Theodore W, Avanzini G (2011) Immune-mediated epilepsies. Epilepsia 52(Suppl 3):5–11PubMedCentralPubMedGoogle Scholar
  52. Haginoya K, Noguchi R, Zhao Y, Munakata M, Yokoyama H, Tanaka S, Hino-Fukuyo N, Uematsu M, Yamamoto K, Takayanagi M, Iinuma K, Tsuchiya S (2009) Reduced levels of interleukin-1 receptor antagonist in the cerebrospinal fluid in patients with West syndrome. Epilepsy Res 85:314–317PubMedGoogle Scholar
  53. Harper E, Moses H, Lagrange A (2007) Occult celiac disease presenting as epilepsy and MRI changes that responded to gluten-free diet. Neurology 68:533–534PubMedGoogle Scholar
  54. Harre EM, Galic MA, Mouihate A, Noorbakhsh F, Pittman QJ (2008) Neonatal inflammation produces selective behavioural deficits and alters N-methyl-D-aspartate receptor subunit mRNA in the adult rat brain. Eur J Neurosci 27:644–653PubMedCentralPubMedGoogle Scholar
  55. Hart YM, Andermann F, Fish DR, Dubeau F, Robitaille Y, Rasmussen T, Berkovic S, Marino R, Yakoubian EM, Spillane K, Scaravilli F (1997) Chronic encephalitis and epilepsy in adults and adolescents: a variant of Rasmussen’s syndrome? Neurology 48:418–424PubMedGoogle Scholar
  56. Harvey L, Boksa P (2012) Prenatal and postnatal animal models of immune activation: relevance to a range of neurodevelopmental disorders. Dev Neurobiol 72:1335–1348PubMedGoogle Scholar
  57. Henchey R, Cibula J, Helveston W, Malone J, Gilmore RL (1995) Electroencephalographic findings in Hashimoto's encephalopathy. Neurology 45:977–981PubMedGoogle Scholar
  58. Howell KB, Katanyuwong K, Mackay MT, Bailey CA, Scheffer IE, Freeman JL, Berkovic SF, Harvey AS (2012) Long-term follow-up of febrile infection-related epilepsy syndrome. Epilepsia 53:101–110PubMedGoogle Scholar
  59. Hu S, Sheng WS, Ehrlich LC, Peterson PK, Chao CC (2000) Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 7:153–159PubMedGoogle Scholar
  60. Irani SR, Buckley C, Vincent A, Cockerell OC, Rudge P, Johnson MR, Smith S (2008) Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 71:1647–1648PubMedGoogle Scholar
  61. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133:2734–2748PubMedCentralPubMedGoogle Scholar
  62. Kim YS, Sheldon RA, Elliott BR, Liu Q, Ferriero DM, Tauber MG (1995) Brain injury in experimental neonatal meningitis due to group B streptococci. J Neuropathol Exp Neurol 54:531–539PubMedGoogle Scholar
  63. Kinnunen E, Wikstrom J (1986) Prevalence and prognosis of epilepsy in patients with multiple sclerosis. Epilepsia 27:729–733PubMedGoogle Scholar
  64. Kolarova A, Ringer R, Tauber MG, Leib SL (2003) Blockade of NMDA receptor subtype NR2B prevents seizures but not apoptosis of dentate gyrus neurons in bacterial meningitis in infant rats. BMC Neurosci 4:21PubMedCentralPubMedGoogle Scholar
  65. Kondo Y, Okumura A, Watanabe K, Negoro T, Kato T, Kubota T, Hiroko K (2005) Comparison of two low dose ACTH therapies for West syndrome: their efficacy and side effect. Brain Dev 27:326–330PubMedGoogle Scholar
  66. Kothbauer-Margreiter I, Sturzenegger M, Komor J, Baumgartner R, Hess CW (1996) Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol 243:585–593PubMedGoogle Scholar
  67. Kramer U, Chi CS, Lin KL, Specchio N, Sahin M, Olson H, Nabbout R, Kluger G, Lin JJ, van Baalen A (2011) Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia 52:1956–1965PubMedGoogle Scholar
  68. Labate A, Gambardella A, Messina D, Tammaro S, Le Piane E, Pirritano D, Cosco C, Doldo P, Mazzei R, Oliveri RL, Bosco D, Zappia M, Valentino P, Aguglia U, Quattrone A (2001) Silent celiac disease in patients with childhood localization-related epilepsies. Epilepsia 42:1153–1155PubMedGoogle Scholar
  69. Lagae LG, Silberstein J, Gillis PL, Casaer PJ (1998) Successful use of intravenous immunoglobulins in Landau-Kleffner syndrome. Pediatr Neurol 18:165–168PubMedGoogle Scholar
  70. Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, Cowell JK, Dalmau J (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9:776–785PubMedCentralPubMedGoogle Scholar
  71. Lancaster E, Martinez-Hernandez E, Dalmau J (2011) Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 77:179–189PubMedCentralPubMedGoogle Scholar
  72. Landau WM, Kleffner FR (1957) Syndrome of acquired aphasia with convulsive disorder in children. Neurology 7:523–530PubMedGoogle Scholar
  73. Leach JP, Chadwick DW, Miles JB, Hart IK (1999) Improvement in adult-onset Rasmussen’s encephalitis with long-term immunomodulatory therapy. Neurology 52:738–742PubMedGoogle Scholar
  74. Lee SH, Han SH, Lee KW (2000) Kainic acid-induced seizures cause neuronal death in infant rats pretreated with lipopolysaccharide. Neuroreport 11:507–510PubMedGoogle Scholar
  75. Libbey JE, Fujinami RS (2011) Neurotropic viral infections leading to epilepsy: focus on Theiler’s murine encephalomyelitis virus. Future Virol 6:1339–1350PubMedCentralPubMedGoogle Scholar
  76. Libbey JE, Kennett NJ, Wilcox KS, White HS, Fujinami RS (2011) Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection. J Virol 85:6913–6922PubMedCentralPubMedGoogle Scholar
  77. Librizzi L, Noe F, Vezzani A, de Curtis M, Ravizza T (2012) Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol 72:82–90PubMedGoogle Scholar
  78. Lionetti E, Francavilla R, Pavone P, Pavone L, Francavilla T, Pulvirenti A, Giugno R, Ruggieri M (2010) The neurology of coeliac disease in childhood: what is the evidence? A systematic review and meta-analysis. Dev Med Child Neurol 52:700–707PubMedGoogle Scholar
  79. Liu ZS, Wang QW, Wang FL, Yang LZ (2001) Serum cytokine levels are altered in patients with West syndrome. Brain Dev 23:548–551PubMedGoogle Scholar
  80. Liu J, Reeves C, Michalak Z, Coppola A, Diehl B, Sisodiya SM, Thom M (2014) Evidence for mTOR pathway activation in a spectrum of epilepsy-associated pathologies. Acta Neuropathol Commun 2:71PubMedCentralPubMedGoogle Scholar
  81. Lousa M, Sanchez-Alonso S, Rodriguez-Diaz R, Dalmau J (2000) Status epilepticus with neuron-reactive serum antibodies: response to plasma exchange. Neurology 54:2163–2165PubMedGoogle Scholar
  82. Ludvigsson JF, Zingone F, Tomson T, Ekbom A, Ciacci C (2012) Increased risk of epilepsy in biopsy-verified celiac disease: a population-based cohort study. Neurology 78:1401–1407PubMedGoogle Scholar
  83. Mackworth-Young CG, Hughes GR (1985) Epilepsy: an early symptom of systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 48:185PubMedCentralPubMedGoogle Scholar
  84. Maiese K, Chong ZZ, Shang YC, Wang S (2013) mTOR: on target for novel therapeutic strategies in the nervous system. Trends Mol Med 19:51–60PubMedCentralPubMedGoogle Scholar
  85. Maki M, Collin P (1997) Coeliac disease. Lancet 349:1755–1759PubMedGoogle Scholar
  86. Mantegazza R, Bernasconi P, Baggi F, Spreafico R, Ragona F, Antozzi C, Bernardi G, Granata T (2002) Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 131:179–185PubMedGoogle Scholar
  87. Marchi N, Granata T, Ghosh C, Janigro D (2012) Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches. Epilepsia 53:1877–1886PubMedGoogle Scholar
  88. Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, Rossetti C, Molteni M, Casalgrandi M, Manfredi AA, Bianchi ME, Vezzani A (2010) Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 16:413–419PubMedGoogle Scholar
  89. Maroso M, Balosso S, Ravizza T, Iori V, Wright CI, French J, Vezzani A (2011) Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurother 8:304–315Google Scholar
  90. Matthews WB (1962) Epilepsy and disseminated sclerosis. Q J Med 31:141–155PubMedGoogle Scholar
  91. Mavroudi A, Karatza E, Papastavrou T, Panteliadis C, Spiroglou K (2005) Successful treatment of epilepsy and celiac disease with a gluten-free diet. Pediatr Neurol 33:292–295PubMedGoogle Scholar
  92. McLachlan RS, Girvin JP, Blume WT, Reichman H (1993) Rasmussen's chronic encephalitis in adults. Arch Neurol 50:269–274PubMedGoogle Scholar
  93. Mikati MA, Saab R (2000) Successful use of intravenous immunoglobulin as initial monotherapy in Landau-Kleffner syndrome. Epilepsia 41:880–886PubMedGoogle Scholar
  94. Mirrione MM, Konomos DK, Gravanis I, Dewey SL, Aguzzi A, Heppner FL, Tsirka SE (2010) Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice. Neurobiol Dis 39:85–97PubMedCentralPubMedGoogle Scholar
  95. Nabbout R, Vezzani A, Dulac O, Chiron C (2011) Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol 10:99–108PubMedGoogle Scholar
  96. Nguyen MD, Julien JP, Rivest S (2002) Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 3:216–227PubMedGoogle Scholar
  97. Nobile C, Michelucci R, Andreazza S, Pasini E, Tosatto SC, Striano P (2009) LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy. Hum Mutat 30:530–536PubMedGoogle Scholar
  98. Nolte KW, Unbehaun A, Sieker H, Kloss TM, Paulus W (2000) Hashimoto encephalopathy: a brainstem vasculitis? Neurology 54:769–770PubMedGoogle Scholar
  99. Palmer CA, Geyer JD, Keating JM, Gilliam F, Kuzniecky RI, Morawetz RB, Bebin EM (1999) Rasmussen’s encephalitis with concomitant cortical dysplasia: the role of GluR3. Epilepsia 40:242–247PubMedGoogle Scholar
  100. Peachardre JC, Sauvezie B, Osier C, Gilbert J (1977) Traitment does encéphalopathies épileptiques de l’enfant par les gamma globulines. Rev Electroencephalogr Neurophysiol Clin 7:443–447Google Scholar
  101. Peltola JT, Haapala A, Isojarvi JI, Auvinen A, Palmio J, Latvala K, Kulmala P, Laine S, Vaarala O, Keranen T (2000) Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. Am J Med 109:712–717PubMedGoogle Scholar
  102. Peltola M, Kaukinen K, Dastidar P, Haimila K, Partanen J, Haapala AM, Maki M, Keranen T, Peltola J (2009) Hippocampal sclerosis in refractory temporal lobe epilepsy is associated with gluten sensitivity. J Neurol Neurosurg Psychiatry 80:626–630PubMedGoogle Scholar
  103. Ranua J, Luoma K, Auvinen A, Maki M, Haapala AM, Peltola J, Raitanen J, Isojarvi J (2005) Celiac disease-related antibodies in an epilepsy cohort and matched reference population. Epilepsy Behav 6:388–392PubMedGoogle Scholar
  104. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A (2008) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29:142–160PubMedGoogle Scholar
  105. Reid AY, Riazi K, Campbell Teskey G, Pittman QJ (2013) Increased excitability and molecular changes in adult rats after a febrile seizure. Epilepsia 54:e45–e48PubMedGoogle Scholar
  106. Riazi K, Galic MA, Pittman QJ (2010) Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res 89:34–42PubMedGoogle Scholar
  107. Ruggieri M, Incorpora G, Polizzi A, Parano E, Spina M, Pavone P (2008) Low prevalence of neurologic and psychiatric manifestations in children with gluten sensitivity. J Pediatr 152:244–249PubMedGoogle Scholar
  108. Russo E, Citraro R, Donato G, Camastra C, Iuliano R, Cuzzocrea S, Constanti A, De Sarro G (2013) mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy. Neuropharmacology 69:25–36PubMedGoogle Scholar
  109. Russo E, Andreozzi F, Iuliano R, Dattilo V, Procopio T, Fiume G, Mimmi S, Perrotti N, Citraro R, Sesti G, Constanti A, De Sarro G (2014) Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release. Brain Behav Immun.Google Scholar
  110. Saiz A, Blanco Y, Sabater L, Gonzalez F, Bataller L, Casamitjana R, Ramio-Torrenta L, Graus F (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131:2553–2563PubMedGoogle Scholar
  111. Sander JW, Hart YM, Johnson AL, Shorvon SD (1990) National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet 336:1267–1271PubMedGoogle Scholar
  112. Sansing LH, Tuzun E, Ko MW, Baccon J, Lynch DR, Dalmau J (2007) A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 3:291–296PubMedCentralPubMedGoogle Scholar
  113. Shiihara T, Miyashita M, Yoshizumi M, Watanabe M, Yamada Y, Kato M (2010) Peripheral lymphocyte subset and serum cytokine profiles of patients with West syndrome. Brain Development 32:695–702PubMedGoogle Scholar
  114. Silveira G, de Oliveira AC, Teixeira AL (2012) Insights into inflammation and epilepsy from the basic and clinical sciences. J Clin Neurosci 19:1071–1075PubMedGoogle Scholar
  115. Specchio N, Fusco L, Claps D, Vigevano F (2010) Epileptic encephalopathy in children possibly related to immune-mediated pathogenesis. Brain Development 32:51–56PubMedGoogle Scholar
  116. Stellwagen D, Beattie EC, Seo JY, Malenka RC (2005) Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 25:3219–3228PubMedGoogle Scholar
  117. Stewart KA, Wilcox KS, Fujinami RS, White HS (2010) Development of postinfection epilepsy after Theiler’s virus infection of C57BL/6 mice. J Neuropathol Exp Neurol 69:1210–1219PubMedCentralPubMedGoogle Scholar
  118. Striano P, Orefice G, Brescia Morra V, Boccella P, Sarappa C, Lanzillo R, Vacca G, Striano S (2003) Epileptic seizures in multiple sclerosis: clinical and EEG correlations. Neurol Sci 24:322–328PubMedGoogle Scholar
  119. Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157–165PubMedCentralPubMedGoogle Scholar
  120. Tobias SM, Robitaille Y, Hickey WF, Rhodes CH, Nordgren R, Andermann F (2003) Bilateral Rasmussen encephalitis: postmortem documentation in a five-year-old. Epilepsia 44:127–130PubMedGoogle Scholar
  121. Trouillas P, Courjon J (1972) Epilepsy with multiple sclerosis. Epilepsia 13:325–333PubMedGoogle Scholar
  122. Tsuji T, Okumura A, Ozawa H, Ito M, Watanabe K (2007) Current treatment of West syndrome in Japan. J Child Neurol 22:560–564PubMedGoogle Scholar
  123. Tuzun E, Dalmau J (2007) Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 13:261–271PubMedGoogle Scholar
  124. van Baalen A, Hausler M, Boor R, Rohr A, Sperner J, Kurlemann G, Panzer A, Stephani U, Kluger G (2010) Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia 51:1323–1328PubMedGoogle Scholar
  125. van Baalen A, Hausler M, Plecko-Startinig B, Strautmanis J, Vlaho S, Gebhardt B, Rohr A, Abicht A, Kluger G, Stephani U, Probst C, Vincent A, Bien CG (2012) Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES. Neuropediatrics 43:209–216PubMedGoogle Scholar
  126. Vasconcellos E, Pina-Garza JE, Fakhoury T, Fenichel GM (1999) Pediatric manifestations of Hashimoto’s encephalopathy. Pediatr Neurol 20:394–398PubMedGoogle Scholar
  127. Vezzani A, Ravizza T, Balosso S, Aronica E (2008) Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia 49(Suppl 2):24–32PubMedGoogle Scholar
  128. Vezzani A, Aronica E, Mazarati A, Pittman QJ (2011a) Epilepsy and brain inflammation. Exp Neurol.Google Scholar
  129. Vezzani A, French J, Bartfai T, Baram TZ (2011b) The role of inflammation in epilepsy. Nat Rev Neurol 7:31–40PubMedCentralPubMedGoogle Scholar
  130. Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T (2011c) IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 25:1281–1289PubMedGoogle Scholar
  131. Vezzani A, Balosso S, Ravizza T (2012) Inflammation and epilepsy. Handb Clin Neurol 107:163–175PubMedGoogle Scholar
  132. Vincent A, Crino PB (2011) Systemic and neurologic autoimmune disorders associated with seizures or epilepsy. Epilepsia 52(Suppl 3):12–17PubMedGoogle Scholar
  133. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S, Lang B, Rossor MN, Palace J (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127:701–712PubMedGoogle Scholar
  134. Vincent A, Bien CG, Irani SR, Waters P (2011a) Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 10:759–772PubMedGoogle Scholar
  135. Vincent A, Irani SR, Lang B (2011b) Potentially pathogenic autoantibodies associated with epilepsy and encephalitis in children and adults. Epilepsia 52(Suppl 8):8–11PubMedGoogle Scholar
  136. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M (2003) Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23:8692–8700PubMedGoogle Scholar
  137. Wang S, Cheng Q, Malik S, Yang J (2000) Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J Pharmacol Exp Ther 292:497–504PubMedGoogle Scholar
  138. Wang SJ, Bo QY, Zhao XH, Yang X, Chi ZF, Liu XW (2013) Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling. Brain Res 1492:122–129PubMedGoogle Scholar
  139. Watson R, Jiang Y, Bermudez I, Houlihan L, Clover L, McKnight K, Cross JH, Hart IK, Roubertie A, Valmier J, Hart Y, Palace J, Beeson D, Vincent A, Lang B (2004) Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology 63:43–50PubMedGoogle Scholar
  140. Wennberg RA, Quesney LF, Villemure JG (1997) Epileptiform and non-epileptiform paroxysmal activity from isolated cortex after functional hemispherectomy. Electroencephalogr Clin Neurophysiol 102:437–442PubMedGoogle Scholar
  141. Wiendl H, Bien CG, Bernasconi P, Fleckenstein B, Elger CE, Dichgans J, Mantegazza R, Melms A (2001) GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen’s encephalitis. Neurology 57:1511–1514PubMedGoogle Scholar
  142. Yamamoto H, Fukuda M, Miyamoto Y, Murakami H, Kamiyama N (2007) A new trial liposteroid (dexamethasone palmitate) therapy for intractable epileptic seizures in infancy. Brain Dev 29:421–424PubMedGoogle Scholar
  143. Zelnik N, Pacht A, Obeid R, Lerner A (2004) Range of neurologic disorders in patients with celiac disease. Pediatrics 113:1672–1676PubMedGoogle Scholar
  144. Zhou YD, Lee S, Jin Z, Wright M, Smith SE, Anderson MP (2009) Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med 15:1208–1214PubMedCentralPubMedGoogle Scholar
  145. Zuliani L, Graus F, Giometto B, Bien C, Vincent A (2012) Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry 83:638–645PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Laura Mumoli
    • 1
  • Angelo Labate
    • 1
    • 2
  • Antonietta Coppola
    • 3
  • Giovambattista De Sarro
    • 4
  • Emilio Russo
    • 4
    Email author
  • Antonio Gambardella
    • 1
    • 2
  1. 1.Institute of NeurologyUniversity “Magna Graecia” of CatanzaroCatanzaroItaly
  2. 2.Institute of Molecular Bioimaging and PhysiologyNational Research Council (IBFM-CNR)GermanetoItaly
  3. 3.Epilepsy Centre, Department of Neuroscience, Reproductive and Odontostomatological SciencesFederico II UniversityNaplesItaly
  4. 4.Department of Health SciencesUniversity “Magna Graecia” of CatanzaroCatanzaroItaly

Personalised recommendations